Advanced search
Publication Cover
OncoImmunology Volume 12, 2023 - Issue 1
Submit an article Journal homepage
2,516
Views
2
CrossRef citations to date
0
Altmetric
Commentary

Ferroptosis: friend or foe in cancer immunotherapy?

Robin Demuyncka Cell Death Investigation and Therapy (CDIT) Laboratory, Department of Human Structure and Repair, Ghent University, Ghent, Belgium;b Cancer Research Institute Ghent, Ghent, BelgiumView further author information
,
Iuliia Efimovaa Cell Death Investigation and Therapy (CDIT) Laboratory, Department of Human Structure and Repair, Ghent University, Ghent, Belgium;b Cancer Research Institute Ghent, Ghent, BelgiumView further author information
,
Elena Catanzaroa Cell Death Investigation and Therapy (CDIT) Laboratory, Department of Human Structure and Repair, Ghent University, Ghent, Belgium;b Cancer Research Institute Ghent, Ghent, BelgiumView further author information
&
Dmitri V Kryskoa Cell Death Investigation and Therapy (CDIT) Laboratory, Department of Human Structure and Repair, Ghent University, Ghent, Belgium;b Cancer Research Institute Ghent, Ghent, BelgiumCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9692-2047View further author information
ORCID Icon
Article: 2182992 | Received 07 Feb 2023, Accepted 16 Feb 2023, Published online: 23 Feb 2023

References

  • Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25(3):486–3. doi:10.1038/s41418-017-0012-4.
  • Dixon SJ, Lemberg K, Lamprecht M, Skouta R, Zaitsev E, Gleason C, Patel D, Bauer A, Cantley A, Yang W, et al. Ferroptosis: An Iron-Dependent Form of Non-Apoptotic Cell Death. Cell. 2012;149(5):1060–1072. doi:10.1016/j.cell.2012.03.042.
  • Friedmann Angeli JP, Krysko DV, Conrad M. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat Rev Cancer. 2019;19(7):405–414. doi:10.1038/s41568-019-0149-1.
  • Demuynck R, Efimova I, Naessens F, Krysko DV. Immunogenic ferroptosis and where to find it? J Immunother Cancer. 2021;9(e003430):e003430. doi:10.1136/jitc-2021-003430.
  • Efimova I, Catanzaro E, Van der Meeren L, Turubanova VD, Hammad H, Mishchenko TA, Vedunova MV, Fimognari C, Bachert C, Coppieters F, et al. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity. J Immunother Cancer. 2020;8(e001369):e001369. doi:10.1136/jitc-2020-001369.
  • Kroemer G, Galassi C, Zitvogel L, Galluzzi L. Immunogenic cell stress and death. Nat. Immunol. 2022;23(4):487–500. doi:10.1038/s41590-022-01132-2.
  • Liu J, Zhu S, Zeng L, Li J, Klionsky DJ, Kroemer G, Jiang J, Tang D, Kang R, et al. DCN released from ferroptotic cells ignites AGER-dependent immune responses. Autophagy. 2021;1–14. doi:10.1080/15548627.2021.2008692.
  • Kim R, Hashimoto A, Markosyan N, Tyurin VA, Tyurina YY, Kar G, Fu S, Sehgal M, Garcia-Gerique L, Kossenkov A, et al. Ferroptosis of tumour neutrophils causes immune suppression in cancer. Nature. 2022;612(7939):338–346. doi:10.1038/s41586-022-05443-0.
  • Dierge E, Debock E, Guilbaud C, Corbet C, Mignolet E, Mignard L, Bastien E, Dessy C, Larondelle Y, Feron O, et al. Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects. Cell Metab. 2021;33(8):1701–1715.e5. doi:10.1016/J.CMET.2021.05.016.
  • Wiernicki B, Maschalidi S, Pinney J, Adjemian S, Vanden Berghe T, Ravichandran KS, Vandenabeele P. Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity. Nat Commun. 2022;13(3676). doi:10.1038/s41467-022-31218-2.
  • Clement CC, Nanaware PP, Yamazaki T, Negroni MP, Ramesh K, Morozova K, Thangaswamy S, Graves A, Kim HJ, Li TW, et al. Pleiotropic consequences of metabolic stress on the major histocompatibility complex class II molecule antigen processing and presentation machinery. Immunity. 2021;S1074-7613(21) 00085–6. doi:10.1016/j.immuni.2021.02.019.
  • Tang D, Billiar TR, Lotze MT. Tale of Two Active High Mobility Group Box 1 (HMGB1) Redox States. Mol. Med. 2012;18(10):1360–1362. doi:10.2119/molmed.2012.00314.
  • Hayashi K, Nikolos F, Lee YC, Jain A, Tsouko E, Gao H, Kasabyan A, Leung HE, Osipov A, Jung SY, et al. Tipping the immunostimulatory and inhibitory DAMP balance to harness immunogenic cell death. Nat. Commun. 2020;11(6299). doi:10.1038/s41467-020-19970-9.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.